In this retrospective case-control study of 1173 subjects with suspected pulmonary embolism, the 6-month rate of major adverse events (venous thromboembolic, major bleeding, or death) was lower following contrast-enhanced magnetic resonance angiography (MRA) (5.4%) than following computed tomographic angiography (CTA) (13.4%, p < 0.001). The technical success rate of MRA (92.6%) and CTA (90.5%) performed in a routine clinical setting did not differ significantly (p = 0.41). MRA is a clinically effective imaging exam for the primary evaluation of pulmonary embolism.
This abstract and the presentation materials are available to members only; a login is required.